Targeted Strategies for Today's Evolving Markets

MissionIR Blog

InVivo Therapeutics Holdings Corp. (NVIV) Starts Presentation at the Inaugural Marcum MicroCap Conference

InVivo Therapeutics Holdings (OTCQB: NVIV) is a medical device company focused on the development and commercialization of groundbreaking technologies for the treatment of spinal cord injuries (SCI). The company was founded on the basis of proprietary technology co-invented by Robert Langer, Sc.D., Institute Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who is affiliated with Massachusetts General Hospital in Boston. For more information visit the company’s Web site at www.invivotherapeutics.com

Marcum offers an extensive range of professional services and a high degree of specialization. In addition to traditional accounting, assurance, and tax, including domestic and international tax planning and preparation, the firm’s professional services include mergers and acquisition planning, family office services, forensic accounting, and litigation support. For more information on Marcum, visit www.marcumllp.com

Let us hear your thoughts below:

The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
This entry was posted in Marcum MicroCap. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *